A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

"We are seeing more and more treatment trials ... for both Alzheimer's and Lewy body diseases. Having validated clinical criteria to diagnose DLB before dementia hits means we can prevent it ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that topline results from the ...

The company focuses on developing treatments for age-related neurologic ... at the 8th International Lewy Body Dementia Conference in Amsterdam. The topline results will be presented by John ...

First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...

Jan. 28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...

Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...

In addition, zervimesine treatment allowed patients to maintain ... University of Miami Miller School of Medicine and the Lewy Body Dementia Association (LBDA). About Zervimesine (CT1812 ...

CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...